ArticleCureus2025
Ultrasound-Guided Hydrodilatation Versus Corticosteroid Injection for Adhesive Capsulitis: A Pilot Randomized Comparative Study.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Effect of Retatrutide, a Novel Triple Receptor Agonist, on Blood Pressure and Lipid Levels: A Systematic Review and Meta-analysis of Randomized Controlled Trials.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives This pilot randomized comparative study aimed to evaluate the feasibility and preliminary effectiveness of ultrasound-guided hydrodilatation (HD) compared with intra-articular corticosteroid injection (IAI) in patients with adhesive capsulitis at six weeks. Methods A prospective, single-blind, feasibility randomized comparative study was conducted in a tertiary rheumatology centre. Twenty patients with adhesive capsulitis were recruited and randomized equally to receive HD (n = 10) and IAI (n = 10). The primary outcome measures included the Shoulder Pain and Disability Index (SPADI) score, QuickDASH questionnaire score, pain visual analogue scale (VAS), and range of motion (ROM) at six weeks post-intervention. Results Results were reported as mean (± SEM, SD) or median (interquartile range), depending on the distribution of the data. At six weeks, the pain VAS scores were 5 (2, 6) and 1.5 (0.25, 3.75) in the HD and IAI groups, respectively, with P = 0.36. SPADI-Pain scores were 37.8 (17.7-57.8) and 25.3 (5.6-45.0) in the HD and IAI groups, respectively, with P = 0.325. SPADI-Disability scores were 47.3 (26.3-68.3) and 28.5 (8.1-48.9) in the HD and IAI groups, respectively, with P = 0.1602. Median QuickDASH scores were 29.1 (14.5, 41.8) and 13.6 (4.5, 27.3) in the HD and IAI groups, respectively, with P = 0.437. Active and passive ROM also showed no in-between group differences. Conclusion No short-term differences between HD and IAI were seen in all the domains studied. Both treatment groups demonstrated improvement in pain and function at six weeks. However, we are unable to conclude that the two treatments have equivalent effectiveness due to the pilot design. The preliminary data may be used to inform larger studies with longer follow-up to determine optimal treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.